Samsara BioCapital

Samsara BioCapital

$71,500,000 Venture capital (Series B)
FinSMEs

A2 Biotherapeutics Closes $71.5M Series B Funding

$100,000,000 Undisclosed
FinSMEs

Flame Biosciences Completes $100M Common Stock Financing

$239,000,000 Venture capital (Series D)
FinSMEs

Recursion Raises $239M in Series D Equity Financing

Forbes Tech

Recursion Pharmaceuticals Raises $239 Million And Partners With Bayer For AI Drug Discovery

$106,000,000 Post-IPO equity
FinSMEs

Chinook Therapeutics Raises $106M in Funding

GeekWire

Chinook Therapeutics raises $106M as it prepares to merge with Aduro Biotech

$93,500,000 Venture capital (Series C)
FinSMEs , Xconomy

Bolt Biotherapeutics Raises $93.5M in Series C Financing

$76,000,000 Venture capital (Series B)
Pulse 2.0

Autobahn Therapeutics Raises $76 Million To Develop Therapies For CNS Disorders

FinSMEs

Autobahn Therapeutics Raises $76M in Series B Financing

GeekWire

Chinook Therapeutics to merge with Aduro Biotech as it pushes forward with kidney disease therapies

Xconomy

Chinook, Aduro Merger Plan Sets Up New Kidney Disease-Focused Biotech

$45,000,000 Venture capital (Series C)
FinSMEs

Palvella Therapeutics Closes $45M Series C Financing Round

$170,000,000 Venture capital (Series B)
FinSMEs

ElevateBio Raises $170M in Series B Financing

TechCrunch

Cell and gene therapy startup ElevateBio raises $170 million

$100,000,000 Venture capital (Series D)
FinSMEs

Forma Therapeutics Closes $100M Series D Financing

$113,800,000 IPO
PE HUB

Biopharma firm Atreca goes public

$150,000,000 Venture capital (Series A)
PE HUB

ElevateBio racks up $150 mln Series A

$10,000,000 Venture capital
FinSMEs

Palvella Therapeutics Receives $10M in Funding

PE HUB

VC-backed Sutro Biopharma debuts IPO

$125,000,000 Venture capital (Series C)
FinSMEs , PE HUB , MedCity News

Atreca Raises $125M in Series C Funding

Funding